Navigation Links
Small Spreads of Breast Cancer May Not Affect Survival
Date:1/20/2011

By Kathleen Doheny
HealthDay Reporter

WEDNESDAY, Jan. 19 (HealthDay News) -- For decades, doctors have debated about how to best determine whether a patient's breast cancer has spread, especially in the earliest cases of metastases.

Now, researchers have compared two approaches -- a sentinel lymph node biopsy alone, or the sentinel biopsy combined with axillary dissection, which is a more invasive procedure that can spot hidden, smaller metastases. The finding: As long as the larger metastases (2 millimeters in diameter and up) are found, the outcomes of the two procedures are similar.

"What we showed was the significance of these small micrometastases is very small," explained study author Dr. Donald L. Weaver, a professor of pathology at the University of Vermont College of Medicine and Vermont Cancer Center. The report is published in the Jan. 19 online edition of the New England Journal of Medicine.

Weaver and his team randomly assigned 5,611 women with breast cancer but clinically negative axillary nodes to one of two groups -- about half underwent the sentinel node biopsy alone and the other half underwent the biopsy plus axillary dissection.

A sentinel lymph node is the first lymph node to which cancer is likely to spread. The biopsy is based on the idea that cancer cells metastasize in an orderly fashion.

At the centers participating in the study, the sentinel node exam was designed to find all metastases more than 2 millimeters in dimension, known as macrometastases.

Follow-up data was available for 1,924 in the combination group and 1,960 in the biopsy-only group. In the biopsy-only group, 300 were positive for metastases, while 316 were positive in the combination group.

Of those who had metastases, 172 were micrometastases, 14 had macrometastases and 430 had even tinier spreads, known as isolated tumor-cell clusters, the study authors found.

The researchers looked at differences in the patients in whom the hidden metastases were found and in those in which they weren't found. They compared overall survival, disease-free survival and distant-disease-free survival.

"If you had them, the [overall] survival was 94.6 percent; if not, 95.8. There's only a 1.2 percent difference between the two," Weaver said.

While the difference was significant from a statistical point of view, it was slight from a clinical point of view, he noted.

For women, Weaver said, the take-home message is not to be concerned about metastases being missed, provided the sentinel lymph node biopsy was done.

"Enough is enough as long as you find the macrometastases, the ones over 2 millimeters," he said.

As for the smaller spreads? "They are probably being treated by whatever cancer treatment is recommended [for the primary tumor]," he said, such as chemotherapy, endocrine therapy or radiation.

The new information "kind of solidifies an idea that we know," said Dr. Laura Kruper, an assistant professor of oncology and a breast cancer surgeon at the City of Hope Comprehensive Cancer Center in Duarte, Calif.

What the findings suggest, she said, is that the standard procedure followed by many -- do the sentinel lymph node biopsy alone if it's negative -- seems to be effective.

She added, however, that "we really do need to continue to follow these patients long-term" to see if the differences remain small.

More information

To learn more about sentinel lymph node biopsy, visit the U.S. National Cancer Institute.

SOURCES: Donald L. Weaver, M.D., professor, pathology, University of Vermont College of Medicine and Vermont Cancer Center, Burlington, Vt.; Laura Kruper, M.D., assistant professor, oncology, and breast cancer surgeon, City of Hope Comprehensive Cancer Center, Duarte, Calif.; Jan. 19, 2011, New England Journal of Medicine, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Small molecules may prevent ebola infection
2. MIT neuroscientists explain Proustian effect of small details attached to big memories
3. Deadliest Cancer Getting Smaller Chunk of Research Dollars
4. Small molecule may disarm enemy of cancer-fighting p53
5. Small assist device used in emergency case as twin, heart booster pumps for first time in US
6. Unexpectedly small effects of mutations in bacteria bring new perspectives
7. UCI non-small cell lung cancer study highlights advances in targeted drug therapy
8. Small particles show big promise in beating unpleasant odors
9. Small business success spotlighted by USDA at conference
10. American Chemical Society Webinar focuses on NSFs small business funding programs
11. Health Care Reform Helps Small Businesses Offer Coverage: Report
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Small Spreads of Breast Cancer May Not Affect Survival 
(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which ... evacuation of the facility as part of a disaster drill on October 3rd. , ... and Shelton City Emergency Manager, as well as the Connecticut Long Term Care ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset ... of specialty vendors and unique items from across the nation, this holiday-themed event will ... services offered by the VNA. The boutique will be open Saturday, November 4 ...
(Date:10/13/2017)... NJ (PRWEB) , ... October 13, 2017 , ... Global ... at scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global ... physical activity. The fun run is geared towards children of all ages; it ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2, 2017  AllianceRx Walgreens Prime, the combined central ... and pharmacy benefit manager Prime Therapeutics LLC (Prime), today ... included the unveiling of new signage at its headquarters ... as at a few other company-owned facilities across the ... patients, some of whom will begin to see the ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology: